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Abstract  1 
Purpose: This systematic review and meta-analysis analysed the relationship between dietary 2 
protein and bone health across the life-course.   3 
Methods: The PubMed database was searched for all relevant human studies from the 1st 4 
January 1976 to 22nd January 2016, including all bone outcomes except calcium metabolism.  5 
Results: The searches identified 127 papers for inclusion, including 74 correlational studies, 6 
23 fracture or osteoporosis risk studies and 30 supplementation trials.  Protein intake 7 
accounted for 0 - 4% of areal BMC and areal BMD variance in adults and 0-14% of areal 8 
BMC variance in children and adolescents. However, when confounder adjusted (5 studies) 9 
adult lumbar spine and femoral neck BMD associations were not statistically significant. 10 
There was no association between protein intake and relative risk (RR) of osteoporotic 11 
fractures for total (RR(random) = 0.94; 0.72 to 1.23, I
2=32%), animal (RR (random) = 0.98; 0.76 to 12 
1.27, I2 = 46%) or vegetable protein (RR (fixed)= 0.97 (0.89 to 1.09, I
2 = 15%). In total protein 13 
supplementation studies, pooled effect sizes were not statistically significant for LSBMD 14 
(total n=255, MD(fixed)=0.04 g/cm
2 (0.00 to 0.08, P=0.07), I2=0%) or FNBMD (total n=435, 15 
MD(random)=0.01 g/cm
2 (-0.03 to 0.05, P=0.59), I2=68%).  16 
Conclusions: There appears to be little benefit of increasing protein intake for bone health in 17 
healthy adults but there is also clearly no indication of any detrimental effect, at least within 18 
the protein intakes of the populations studied (around 0.8-1.3 g/Kg/day).  More studies are 19 
urgently required on the association between protein intake and bone health in children and 20 
adolescents. 21 
 22 
Key Words: Aging, Epidemiology, IGF-1, Nutrition, Osteoporosis, Diet 23 
 24 
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Mini Abstract: We undertook a systematic review and meta-analysis of published papers 25 
assessing dietary protein and bone health. We found little benefit of increasing protein intake 26 
for bone health in healthy adults but no indication of any detrimental effect, at least within the 27 
protein intakes of the populations studied. 28 
 29 
  30 
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Introduction    31 
 32 
The association between dietary protein intake and bone health has been debated worldwide 33 
for decades. It is unclear as to whether dietary protein exerts a positive or detrimental 34 
influence on bone and there are competing theories as to the effects of dietary protein on bone 35 
health.  Proponents of a positive link between protein intake and bone health cite the known 36 
anabolic effects of dietary protein on bone, via dietary protein’s known ability to increase 37 
secretion of insulin-like growth factor 1 (IGF-1).  Dietary protein may also increase calcium 38 
absorption from the gut [1], which is likely to be beneficial for bone mineralisation.   39 
On the other hand, proponents of a detrimental association between protein intake and bone 40 
argue that high protein intakes may be bad for bone health. This is on the basis of known in-41 
vitro increased osteoclast activity with increasing body acidity[2] and predicted subsequent 42 
bone demineralisation.  However, it is important to consider dietary protein type as only 43 
proteins that are rich in sulphur amino acids are likely to increase net physiological acid 44 
production. Also, protein is consumed in the diet with other components which may modify 45 
the overall net acid concentration (e.g. fruits and vegetables which have an alkalizing effect, 46 
soy isoflavones which have estrogenic effects, and dairy products which contain calcium). 47 
These nutrients may modify the association between protein intake and bone health [3, 4]. 48 
A previous systematic review and meta-analysis published in 2009, covering published papers 49 
from January 1966 to July 2008 [5], showed a small beneficial effect of dietary protein 50 
supplementation on areal bone mineral density (aBMD) in human adults, as well as showing 51 
that nearly all published cross-sectional studies demonstrate a positive association between 52 
dietary protein intake and bone health. However, there was no association between dietary 53 
protein intake and fracture risk in cohort studies, and much of the findings of the cross-54 
sectional studies may be due to inadequate controlling for confounding factors.  Also, the 55 
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previous systematic review and meta-analysis did not assess dietary protein and bone health 56 
in children and adolescents, which is an important area of research due to the known 57 
importance of obtaining peak bone mass at this time of life.  58 
Since the publication of the dietary protein and bone health systematic review and meta-59 
analysis in 2009 [5] the number of relevant articles on the topic of dietary protein and bone 60 
health has doubled. This highlights the need for an updated systematic review of this topic, 61 
including consideration of peak bone mass development in children and adolescents, as well 62 
as bone health in adults. Further systematic reviews have been conducted on the topic since 63 
2009 [6-10], but none to date have included all study designs (cross-sectional, longitudinal 64 
and randomized control trials) and included both adults and children. Our objective was to 65 
perform a systematic review and meta-analysis of the evidence published over the last 40 66 
years assessing dietary protein intake and all indices of bone health across the human life-67 
course, including all relevant observational and intervention studies examining intakes of all 68 
types of protein. 69 
 70 
Materials and Methods  71 
Search Strategy 72 
The PUBMED databases, as well as reference lists of relevant journal papers were searched to 73 
ensure broad coverage.  The search phrase used for the electronic search was “(protein intake 74 
OR dietary protein OR protein supplement OR protein consumption) AND (bone OR fracture 75 
OR BMD OR bone turnover)” limited to human studies, in any language, from 1st January 76 
1976 to 22nd January 2016. Two of the authors (ALD, SLN) identified potential studies for 77 
inclusion by first screening titles and abstracts, and then looking at the full version of papers 78 
if necessary.  Any disagreements were resolved by consensus and deferred to a third party if 79 
required.   80 
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 81 
Study Design and Criteria 82 
Papers assessing relevant bone outcomes (specifically BMD or BMC, bone turnover markers 83 
and/or fracture risk) in healthy human adults, adolescents or children were considered for 84 
inclusion. Studies investigating subjects with a pre-existing medical condition affecting bone 85 
or calcium metabolism, or studying animals, infants, and pregnant or lactating women were 86 
excluded as were studies involving only calcium balance or calcium metabolism.   87 
All cross-sectional, longitudinal and intervention studies were eligible for inclusion, including 88 
intervention studies of any design.  However, due to problems of statistically combining 89 
crossover and parallel intervention designs, crossover studies were not included in the meta-90 
analysis and were discussed in the systematic review only. Studies were excluded if they were 91 
published before 1975, were weight loss studies, did not have usable protein or bone data, 92 
were not on the relevant topic, were review articles or correspondence, or only had data on 93 
dietary patterns. They were also excluded if they had confounders present in the central study 94 
design (e.g. differing exercise levels in the intervention and control groups as part of the 95 
intervention, for example protein and exercise as intervention vs. no protein and exercise). All 96 
bone sites in the body were eligible for inclusion in the review, as were all markers of bone 97 
metabolism. 98 
Soy protein studies were excluded if they did not have data on isoflavone devoid soy protein 99 
isolate.  Studies on whole dietary measures (e.g. meat intake, frequency of high protein meals) 100 
were also excluded due to the confounding potential of other dietary constituents (such as 101 
isoflavones in soy protein; fat or iron in meat). However, whole diet intervention studies were 102 
included as long as the nutritional contents of the diets were shown in the paper and the diets 103 
had been designed to minimise the impact of confounders (e.g. ensuring high and low protein 104 
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diets were isocaloric, similar in dietary calcium etc.).  No ethical approval was required as the 105 
analysis was conducted only on already published data. 106 
 107 
Data synthesis  108 
See Online Resource for full details of the data extraction process.  In the meta-analyses, two 109 
sided tests with an alpha value of 5% were used, and Bonferroni adjustment for multiple 110 
testing was applied when necessary.   111 
The systematic review included all eligible studies, but only studies with data suitable for 112 
meta-analysis were analysed quantitatively. The R software (version 3.1.2) [11] add-on 113 
packages ‘metacor’[12], ‘meta’[13], ‘metafor’[14] and ‘metagen’[15] were used to pool 114 
correlation coefficients, intervention and fracture risk data for meta-analysis, as well as 115 
creating all plots.  For cross-sectional and longitudinal data, multivariate adjusted analyses 116 
were used wherever possible, rather than unadjusted or age adjusted measures.  Linear and 117 
non-linear modelling was undertaken to assess whether there was an association between 118 
correlation coefficients or actual BMD values with the following: calcium: protein ratio 119 
(mg/g/d); protein dose (g/kg/d) and calcium dose (mg/kg/d). 120 
It was planned a priori to run a combined analysis of hip and non-hip fracture data as all 121 
fracture outcome first, then a subsequent analysis of hip fracture data only. Unfortunately the 122 
calcium: protein ratios (calcium mg/protein g) in the fracture risk studies were too constant 123 
(10-12 mg/g/d) to be able to perform an assessment of calcium: protein ratio vs. fracture risk. 124 
Also, there were too few studies within the same protein type to be able to plot protein or 125 
calcium dose against fracture risk.  126 
The intervention trials meta-analysis examined the main effects of protein supplementation 127 
(all protein types but excluding studies specifically looking at soy protein isolate and milk 128 
basic protein (MBP)) on BMD, BMC and bone turnover markers, based on mean differences. 129 
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The decision was made a priori to also perform a separate analysis for MBP trials as this type 130 
of protein is highly concentrated and is supplemented in very high doses. Similarly, 131 
experience from the previous meta-analysis suggested that soy protein studies need to be 132 
analysed separately than non-soy studies, as soy studies usually assess the effect of soy 133 
protein vs. another protein type (hence the actual protein intake is the same, just different 134 
protein type). Conversely, studies of mixed protein supplementation usually compare higher 135 
with lower doses of protein (or have another type of control, e.g. maltodextrin), hence the 136 
protein intake varies in each arm of the study.   137 
Finally, due to the differences in skeletal biology between early life and in older age, as well 138 
as differences in nutritional requirements, children and adults were analysed separately in all 139 
meta-analyses.  Also, all adult groups were broken down into gender and life stage specific 140 
analyses wherever there was enough data to do so. Only for the cross-sectional studies were 141 
there enough data to perform a meta-analysis in children. 142 
 143 
Heterogeneity, Sensitivity and Publication Bias- meta-analysis 144 
It was pre-specified that the I2 statistic was to be used to assess heterogeneity between studies 145 
as this is recommended for analyses with smaller numbers of studies[16]. I2 values of 25%, 146 
50% and 75% were considered low, moderate and high, respectively[16]. Random-effects 147 
(heterogeneous comparisons) and fixed effects (homogenous comparisons) models were used 148 
accordingly, with the decision based on size of I2 (%), rather than the P(heterogenity) value from 149 
the Q test, as number of studies in the meta-analyses were predicted to be small.  It was also 150 
pre-specified that funnel plots were used to assess possible biases in meta-analyses containing 151 
10 or more studies[17]. Sensitivity analyses were also planned to assess the impact of removal 152 
of each study in turn on the pooled effect size. 153 
 154 
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Quality Analysis 155 
Intervention study quality analysis was undertaken at the study level. This was conducted 156 
independently by 2 authors (AD, SLN) using the Jadad Scale[18].  Due to the extensive 157 
number of observational studies, only one author (AD) assessed quality for these papers, 158 
using the Newcastle-Ottawa adapted scales [19] for cohort and case-control study designs as 159 
appropriate. Cross-sectional studies were not assessed for study quality due to the very large 160 
number of papers included in the review. For all study types, due to the small predicted 161 
numbers of potential studies for the fracture and intervention study meta-analyses, we decided 162 
a priori that the quality analysis information was to be used to guide result interpretation 163 
rather than to exclude studies per se. 164 
 165 
  166 
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Results    167 
 168 
Figure 1 shows the Quality of Reporting of Meta-analyses (QUOROM) flow diagram[20] 169 
illustrating the search and selection process.  The systematic review included 127 studies, 170 
including 74 studies reporting correlation or regression coefficients (Table 1). These included 171 
either just cross-sectional data (55 studies), just longitudinal change data (4 studies) or both (9 172 
studies). These also included  2 studies reporting both longitudinal change in BMD data and 173 
fracture data and 4 studies reporting cross-sectional data and odds of low BMD or 174 
osteoporosis diagnosis (Table 2). In addition there were 23 studies reporting only fracture or 175 
osteoporosis risk (Table 3), and 30 intervention studies (Table 4). Due to the extensive 176 
number of studies to be discussed here, see the Online Resource for the systematic review and 177 
the study quality assessments. 178 
 179 
Pooling of studies reporting correlation or regression coefficients 180 
By population subgroup  181 
See Table 1 (and Online Resource Table S1) for details of the studies reporting correlation 182 
or regression coefficients. Of these 74 studies, 30 studies in adults [21-50] and 5 studies in 183 
children [51-55] gave cross-sectional R correlation coefficients suitable for pooling.  Of note, 184 
only 5 of these studies [22, 24, 25, 36, 56] reported adjusted data, so the majority (n=30) were 185 
non-adjusted for confounders.  When pooling by population subgroup the R2 values suggested 186 
that <1-8% of adult bone BMD or BMC (depending on age and biological sex) as well as 187 
10% of child BMC was explained by protein intake (Online Resource Tables S2-S3, Online 188 
Resource Material Text).  Heterogeneity was highly variable with values ranging from 0-74% 189 
depending on population subgroup. 190 
 191 
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By bone parameter 192 
For adults, Online Resource Figures 1-2 illustrate the pooled effect size for FNBMD and 193 
LSBMD. FNBMD (total n=4786) showed r (fixed)=0.07 (0.04 to 0.09) R
2=0.005 (0.5%) 194 
P<0.0001, I2=26%  P(heterogenity)=0.15.   LSBMD (total n=4257) showed r (random)=0.09 (0.04 to 195 
0.14) R2=0.008 (0.8%) P<0.001, I2=58% P(heterogenity)=0.001. Of note, when only studies 196 
reporting multivariate adjusted data were shown, the pooled effect sizes for FNBMD (total 197 
n=1169, r (random)=0.04 (-0.05 to 0.12) R
2=0.0016 (0.2%) P=0.37, I2=45% P(heterogenity)=0.14), 198 
and for LSBMD (total n=728, r (fixed)=0.0 (-0.07 to 0.07), R
2=0 (0%) P=0.97, I2=0% 199 
P(heterogenity)=0.61) were no longer statistically significant.  Other bone outcomes ranged in R
2 200 
value from 0-10% (including unadjusted data). See Online Resource Material for full results 201 
of pooling for other bone sites in adults. Heterogeneity was highly variable with values 202 
ranging from 0-94% depending on adult bone site.   203 
In children and adolescents, the R2 values suggested that 0-14% of child/adolescent BMC and 204 
21% child/adolescent total body bone area (TBBA) were explained by protein intake (all 205 
unadjusted data). Heterogeneity was 0% (All BMC and total body bone mineral content 206 
(TBBMC)), 79% (TBBA) and 87% total body bone mineral density (TBBMD)). See Online 207 
Resource Material for further details of all the above correlational analyses including 208 
sensitivity analyses and funnel plots, as well as associations with protein and calcium dose, 209 
and calcium: protein ratio (Online Resource Table S4). 210 
 211 
Fracture risk meta-analysis 212 
See Table 3 and Online Resource Table S5 for details of all studies presenting fracture or 213 
osteoporosis risk data. Of 29 studies (6 of which have already appeared in correlational 214 
section of review), 5 studies were pooled in the meta-analysis for cohort studies assessing 215 
relative risk of fracture [57-61] (Figure 2), all of which provided multivariate adjusted risk 216 
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estimates.  No statistically significant association was found between total protein intake and 217 
relative risk (RR) of all fractures (RR (random)=0.94 (0.72 to 1.23, P=0.55 n=4 studies, I
2=32% 218 
P(heterogenity)=0.30). Similar results were seen for animal protein intake, RR(random)=0.98 (0.76 to 219 
1.27, P=0.87, n=4 studies, I2=46% P(heterogenity)=0.13) and vegetable protein intake: 220 
RR(fixed)=0.97 (0.89 to 1.09, P=0.61, n=3 studies,  I
2=15% P(heterogenity)=0.31).  For three cohort 221 
studies reporting hazard ratios (HR) (Online Resource Figure S3)[62-64], no significant 222 
association was found between total protein intake and HR for all fractures (HR (random)=0.82 223 
(0.59 to 1.14, P=0.24), n=4 studies (5 data points as 2 studies had independent subgroups 224 
which can both be entered), I2=35% P(heterogenity)=0.19). Of note, removal of the Sahni (Low 225 
calcium) data[64]  led to a reduced risk of fracture with increased protein intake (HR 226 
(fixed)=0.79 (0.64 to 0.97, P=0.02), n=4 studies, I2=0% P(heterogenity)=0.66), which would 227 
be of borderline statistical significance after adjustment for multiple testing (using a cut-off of 228 
0.02 for 3 fracture meta-analyses). For three case-control studies reporting odds ratio (OR) for 229 
fracture[65-67] (Online Resource Figure S4) there was no significant association between 230 
total protein intake and odds of fracture: (OR (random)=0.69 (0.30 to 1.58, P=0.38), n=4 studies 231 
(4 data points as 1 study had independent subgroups which can both be entered) I2=65% 232 
P(heterogenity)=0.03). See Online Resource Material for details of relevant sensitivity analyses.  233 
 234 
Intervention Studies Meta-analysis 235 
Thirty papers were intervention studies (Table 4, Online Resource Table S6).  See Online 236 
Resource Material for details of study quality assessment for these studies as well as 237 
systematic review of intervention studies.  238 
 239 
 240 
 241 
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Meta-analysis- summary of included studies 242 
Nine of the 30 intervention studies [68-76] were suitable for meta-analysis.  The other 20 243 
studies were excluded due to missing data [77], cross over design study with no report of data 244 
prior to crossover [1, 78-85], and not having data that is compatible with other studies to 245 
allow meta-analysis [86-93], being a food-based intervention [94] or presenting data for 246 
change in bone indices only[95, 96]. 247 
 248 
Total protein intake 249 
The pooled effect size for protein supplementation on LSBMD[68, 72] showed no statistically 250 
significant effect (P=0.07) (total n=255, MD(fixed)=0.04 (0.00 to 0.08, P=0.07), I
2=0% 251 
P(heterogenity)=0.47; Online Resource Figure S5)  Equivalent data for FNBMD (3 studies)[68, 252 
72, 76], were also not statistically significant (total n=435, MD(random)=0.01 (-0.03 to 0.05, 253 
P=0.59) I2=68% P(heterogenity)=0.04)(Online Resource Figure S6).   254 
 255 
MBP and Soy Protein 256 
For MBP studies, comparing MBP supplementation with a nutrient matched drink [69, 70] or 257 
no control[71], the pooled effects sizes were as follows: LSBMD Mean Difference 258 
(MD)(fixed)= 0.02 (0.00-0.04, P=0.08), I
2=0% P(heterogenity)=0.87, 3 studies) (Online Resource 259 
Figure S7).   For soy protein studies no statistically significant effect was found for LSBMD 260 
(MD (random) = -0.01 (-0.07 to 0.06, P=0.82), I
2=51% P(heterogenity)=0.13) , FNBMD (MD (random) 261 
=0.01 (-0.06 to 0.07, P=0.87), I2=74% P(heterogenity)=0.05) or BAP (MD (random) = -1.75 (-10.50 262 
to 7.01, P=0.70), I2=91% P(heterogenity)=0.0009).  There were not enough studies with 263 
compatible data to assess any other bone sites or bone markers for soy protein or MBP 264 
supplementation.  265 
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Overall heterogeneity was low for the influence of MBP on LSBMD at I2=0% but high for 266 
soy protein LSBMD, FNBMD and BAP (I2=51%, 71% and 91% respectively).  For both 267 
MBP and soy protein sensitivity analyses showed that removal of each study in turn had no 268 
effect on the pooled effect sizes (see Online Resource Material).  The results for the soy and 269 
MBP subgroup analyses are unlikely to remain statistically significant after Bonferroni 270 
adjustment for multiple testing. 271 
 272 
  273 
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Discussion  274 
This systematic review and meta-analysis reviewed evidence, published over the last 40 years, 275 
assessing the association between dietary protein and bone health across the life-course. 276 
Dietary protein intake explained 0 to 4% of adult BMD, BMC and bone markers, as well as 0-277 
14% of child/adolescent BMC and 21% child/adolescent TBBA.  However, when only studies 278 
adjusted for confounders (5 studies) were included in the adult analyses for FNBMD and 279 
LSBMD these effects did not remain statistically significant, suggesting the effect sizes seen 280 
could be caused by potential confounding.   The larger pooled effect sizes for the children and 281 
adolescents suggest a stronger relationship between protein and bone health at this life stage 282 
than in later life.   Indeed, nutritional requirements for skeletal growth in childhood and 283 
adolescence are different to those for reducing senescence related bone loss, as the cellular 284 
mechanisms involved differ at these two life stages.  Protein intake may have a strong 285 
relationship with bone health in childhood due to the involvement of amino acids in 286 
endochondral ossification during bone growth. However, this finding of a stronger association 287 
between protein intake and bone health in children may also be an artefact of the smaller 288 
number of participants included in the pooled effect sizes in the child and adolescent analyses 289 
compared with adults.   290 
In adults, neither calcium: protein ratio [calcium (mg)/protein (g /d)] nor protein (g/kg/d) or 291 
calcium (mg/kg/d) dose were associated with strength of effect for the association between 292 
protein intake and bone health. As seen in the previous 2009 systematic review and meta-293 
analysis, there was no association between dietary protein intake and fracture risk in cohort 294 
and case-control studies, for total protein, animal or vegetable protein.  In intervention 295 
studies, no statistically significant effects of total protein supplementation (excluding MBP 296 
and soy protein) were seen for FNBMD and LSBMD, or for higher vs. lower soy protein 297 
supplementation.  298 
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The lack of an effect of dietary protein on bone seen in the above fracture risk and 299 
supplementation trials may be for a variety of reasons.  It could be that the opposing anabolic 300 
and catabolic actions of dietary protein cancel each other out to some extent. Alternatively 301 
dietary protein, at the protein intakes seen in the populations in this review, may not affect 302 
bone health and it may be that there is a small window whereby very low protein intakes are 303 
detrimental to bone, due to low IGF-1 production and dietary calcium absorption from the 304 
gut.   Few studies in the review contained populations with low population intakes, with most 305 
studies reporting intakes of over 0.75g/Kg/d-0.84g/Kg/d which is considered adequate by 306 
western countries such as Australia [97], Europe [98] and the US [99].  Some studies that 307 
contained older people or Buddhist Nuns had intakes nearer to, or slightly lower than, 308 
0.75g/Kg/d [66, 95, 100-102]. Twelve of the trials had no baseline protein intake data which 309 
makes it difficult to fully assess the degree of sufficiency. However, observational studies 310 
included this information with only one observational study not reporting overall protein 311 
intake [42]. In only 2 of the childhood studies was there a deficient protein intake [53, 92], 312 
and these were studies of malnourished children so this is as would be expected. However, 313 
none of the other child or adolescent studies showed deficient protein intakes. 314 
Equally, other aspects of the diet that the authors of the original studies did not control for in 315 
the analysis (e.g. calcium intake) may be affecting the results.  Of note, the study by Sahni et 316 
al. (2010) [64] showed a higher risk of hip fracture with higher protein intake when calcium 317 
intake was low (<800 mg/d) but conversely a lower risk of fracture with higher protein intake 318 
when calcium was higher (≥800 mg/d). Failure to control for calcium intake in the fracture 319 
analyses could therefore obscure any relationship between protein intake and fracture risk. Of 320 
importance, the meta-analysis for cohort studies reporting hazard ratios was borderline 321 
statistically significant for a reduced risk of fracture with increasing protein intake, when the 322 
low calcium arm of the study by Sahni et al.  2010 [64] was removed, suggesting this study 323 
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arm may be masking an association between protein intake and fracture which was evident 324 
when only the high calcium arm was included. Moreover, the meta-analysis result for the 325 
case-control studies (hazard ratios, see Online Resource Figure 4) would have been 326 
statistically significant if using fixed models, which were not used due to heterogeneity 327 
present in our analysis. This may explain some of the differing results of our study from other 328 
meta-analyses, in that other analyses have combined data from cohort and case-control 329 
studies, which we did not, and the results of other meta-analyses may only be significant 330 
because of the inclusion of case-control data. 331 
Since the publication of our original meta-analysis in 2009 [5] there have been a series of 332 
meta-analyses published on the subject of dietary protein and bone [6-9]. However, these 333 
differ from our meta-analysis in significant ways.  Wu et al. (2015) only assessed fracture 334 
risk, and Wallace and Frankenfeld (2017) did not assess cross-sectional studies. Santesso et 335 
al. (2012) only included bone data from weight loss trials and Shams-White et al. (2017) [6]  336 
included a mixture of weight loss and non-weight loss trials, which may partially explain their 337 
finding of a protective effect of higher protein intake against LSBMD loss. Moreover, only 338 
one study in the latter review’s change in LSBMD meta-analysis showed a positive effect, so 339 
the analysis was reliant on this one study for the significant result. The most recent meta-340 
analysis, Shams-White (2018)[10] included only studies on animal protein vs. soy protein 341 
with isoflavones, so differs substantially from our current review. Finally, none of these meta-342 
analyses assessed data from children and adolescents.  343 
There have also been 13 relevant protein and bone health papers [103-115] published since 344 
our electronic searches were completed. All of these studies have found either a positive 345 
association, or no association of protein take with bone health, except for one study which 346 
found poorer bone health with increased protein intake [107]. All these studies were of 347 
observational study design except for two randomised control trials; one of soy protein in 348 
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children which found no effect on bone marker concentration [110] and one of collagen 349 
supplementation in postmenopausal women which found a positive effect of supplementation 350 
on aBMD [108]. Overall, our current meta-analysis reported here is the most comprehensive 351 
to date on the subject and the inclusion of studies published since 2016 are unlikely to have 352 
significantly changed our results. As stated above, the separation of cohort and case-control 353 
studies may explain differences from our study to that of other meta-analyses. 354 
The strengths of this analysis include the fact that we included papers published in both 355 
English and non-English languages, and from both observational and intervention studies. 356 
Moreover, inclusive coverage both in terms of timescale (i.e. 1975 to the present day; 40 357 
years), topic area (all types of protein, BMD, BMC, BA and bone turnover markers) and 358 
population age subgroups (children, adolescents, adults, older adults) was achieved.  This 359 
makes this analysis a comprehensive overview of dietary protein and bone health across the 360 
life-course, using data from the last 40 years.  This makes the work novel and of importance 361 
to scientists, public health providers and clinicians alike.  362 
However, the review was limited by the following factors. First, studies did not vary enough 363 
in calcium intake, as well as too few studies, to be able to assess whether the association 364 
between dietary protein and fracture risk varies by calcium intake.  Second, there were 365 
concerns due to the low methodological quality of some intervention and cross-sectional 366 
studies.  Many cross-sectional studies did not report any multivariate adjusted correlation 367 
coefficients in the paper (only unadjusted r values). Third, there is a clear lack of intervention 368 
studies, particularly parallel trials and cross-over studies reporting data from before the cross-369 
over point, so effect sizes in the intervention meta-analysis are likely to have been 370 
underpowered due to a small number of studies with a small number of participants.  371 
Fourth, the diets of the populations represented in this analysis generally showed protein 372 
intakes that meet (and usually slightly exceed) protein intake recommendations.  Results of 373 
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the analysis could differ if persons with a low protein intake (or very high protein intake) 374 
were included. Indeed, as discussed above, few studies had populations with inadequate 375 
intake and more research is required into bone health in these populations. Moreover, it is also 376 
difficult to answer the question as to whether there is a threshold whereby protein intake 377 
becomes so high that is detrimental to bone due to the lack of data in persons with high 378 
intakes. Fifth, the Newcastle Ottawa tool was not always a good fit to the studies, especially 379 
for nested case-control studies where it is not clear whether they should be scored on the case-380 
control or cohort scales.  Therefore, the results of the quality analysis should be seen as a 381 
general guide to study quality, rather than a definitive and accurate score.  Finally, the funnel 382 
plots for the correlation studies showed some evidence of publication bias in terms of a lack 383 
of small to medium studies showing negative associations between protein intake and bone 384 
health. 385 
Future research needs to include larger-scale intervention studies, particularly in understudied 386 
population sub-groups such as children and adolescents and persons with very low protein 387 
and calcium intakes (e.g. the frail elderly) or very high protein and calcium intakes. Fracture 388 
risk studies need to be undertaken in the elderly, followed up to increased age (e.g. 80s) to 389 
truly see the effect of increased protein intake on long term fracture risk.  390 
Overall, this systematic review and meta-analysis of the association between dietary protein 391 
and bone health across the life-course assessed evidence from the last 40 years. A positive 392 
cross-sectional association was shown between protein intake and bone health in most pooled 393 
analyses of r values in adults. However, these associations disappeared when only covariate 394 
adjusted data were used and there was no association between fracture risk and intake of any 395 
protein type in the fracture risk meta-analysis. There was no effect of any form of protein 396 
supplementation on any indices of bone health.  The public health and clinical implications of 397 
this work are that there may be little benefit of increasing protein intake for bone health in 398 
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healthy adults with an adequate protein intake but there is clearly no indication of any 399 
detrimental effect.  400 
 401 
  402 
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Table 1: Characteristics of 74 cross-sectional and/or longitudinal correlational studies 
Study Design Mean Protein ** Method  Population n Outcomes measured 
Alexy et al, 2005,  Germany[116] CS 1.4-2.0 +/- 0.3 g/Kg/d pQCT Prepubescent and pubescent boys and 
girls 
229 Periosteal Circumference, 
Cortical Area, BMC, Polar SSI 
Alissa et al, 2011, Saudi Arabia[117] CS 1.03 g/Kg/d DXA Postmenopausal women aged 46-70 
years old 
122 BMD 
Alissa et al, 2014, Saudi Arabia[21] CS 71.4+/-1.55 g/d DXA Postmenopausal women, aged 46-88 
years 
300 BMD 
Beasley et al. 2010, USA[118] CS TP: 5.7 - 27.6% energy 
AP:45g/d, VP:19g/d  
DXA Premenopausal women 560 BMD 
Beasley et al. 2014, USA[119] LS 15% total energy DXA Postmenopausal women 50-79 years 144,580 BMD 
Bounds  et al, 2005, USA[51] CS 55g/d (1.9g/Kg/d) DXA 6-8 year old children, 25 Boys and 27 
Girls 
52 BMD/BMC 
Budek et al. 2007a, Denmark [120] CS 2.67 g/Kg/d BTM Pubertal boys 81 OC, BAP, CTX 
Budek et al. 2007b, Denmark [121] CS TP: 1.2 (Girls), 1.3 
(Boys), AP: 0.4 (Girls), 
0.5 (Boys), DP: 0.4 
(Both Girls and Boys) 
g/Kg/d 
DXA 17-year-olds: 63 girls  and 46 boys 109 BMC 
Chan et al, 2009, Hong 
Kong/Beijing[22] 
 
CS 65.4-77.5g/d  DXA Premenopausal women 441 BMD 
Chan et al. 2011, Hong Kong[122] LS 1.3 g/Kg/d DXA Older men and women 2217 BMD 
 
Chevalley et al. 2008, 
Switzerland[52] 
 
 
CS 
 
47.3 g/d, 1.78 g/Kg/d 
 
DXA 
 
Pre-pubertal boys 
 
232 
 
BMC 
Chevalley et al. 2014, 
Switzerland[123] 
LS Age 7: 1.8; Age 15: 1.1 
(g/Kg/d) 
DXA; 
High 
resolutio
n pQCT 
Adolescent boys 176 BMC/BMD/Area at 7.4 and 
15.2 years; HR-pQCT distal 
tibia microstructure 
and strength 
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Study Design Mean Protein ** Method  Population n Outcomes measured 
Chiu et al, 1997, Taiwan  [23] CS 1.09 g/Kg/d DPA 
(BMD) 
Older post F 258 BMD 
Coin et al, Italy, 2008[25] 
 
CS 1.02 g/Kg/d DXA Males, mean age 73.9+/-5.6 years 
 
136 BMD 
Cooper et al, 1996, USA[24] CS 72 g/d DPA 
SPA  
Pre (72) and post (218)  F 290 BMD, HPO. OC 
Dawson-Hughes  et al, 2002, 
USA[124] 
CS 79 g/d 
 
DXA 184 men and women(>=65 years old) 
in placebo (inactive) arm of  calcium 
supplementation trial  
184 BMD, OC, NTX 
Devine et al, 2005, AUS[26] CS 1.2 g/Kg/d DXA , 
QUS 
Elderly F mean age 75y+/-3y 
Caucasian  
1077 BMD, BUA calcaneus 
Ekbote et al, 2011, India[53] CS 18.6g/d-normal and 
malnourished children 
combined 
DXA 2-3 year old children 71 BMC,BA 
Fairweather-Tait et al, 2011, 
UK[125] 
 
CS 81.3g/d DXA Postmenopausal female twin pairs 
(Monozygotic  or dizygotic twins) 
2464 
pairs 
BMD 
Freudenheim et al, 1986, USA[27]  
 
CS 1.02 g/Kg/d SPA Pre and post F, 35-65y, Caucasian 84  BMC 
Geinoz et al, 1993, Switzerland[100] CS Mean Intake in g/d by 
group: 
37.8-59.4 g/d 
DXA Elderly M and F 
Mean age 82y(F); 80y(M) 
74 BMD  
Genaro et al, 2015, Brazil[126] CS 66g/d DXA Women over 65 years old 200 BMC, BMD 
Gregg et al, 1999, USA[29] CS 0.9 g/Kg/d QUS Middle aged (premenopausal) F- 
mean age= 45.5y 
393 BUA Calcaneus, BMD 
Gunn et al, 2014, New  Zealand[28] CS 79g/d BTM, 
DXA 
Postmenopausal women, 60 years of 
age 
142 BMD, CTX,P1NP 
 
Hannan et al. 2000, USA[127] LS 68g/d (16% of total 
energy) 0.97 g/kg/d 
DXA 224 older men and 391 older women  615 BMD 
Henderson et al, 1995 , AUS[30] 
 
CS 1.0 g/Kg/d DXA Pre F- mean age=18y 115 BMD 
Hernandezavila et al, 1993, 
USA[128] 
 
CS 76g/d SPA Women (50-60 years old) 281 BMD 
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Study Design Mean Protein ** Method  Population n Outcomes measured 
Hirota et al, 1992, Japan[31] CS 1.13 g/Kg/d SPA 
(BMD) 
Young PRE women: 19-25y 161 BMD 
 
Ho et al, 2003, China [56] CS 1.01 g/Kg/d SP DXA <12y POST women (48-62y), Asian 454  
 
BMC, BMD 
Ho et al, 2008, China[49] CS 5.2g/d SP 48.6 g/d TP DXA Pre and perimenopausal women 45-
55 years old 
438  BMC, BMD 
Ho-Pham et al, 2009, Vietnam[101] CS TP: 35.4-62.6 g/d DXA 105 Post F 
Buddhist vegan Nuns and 105 
omnivorous women 62+/-10 years 
old 
210  BMD 
Ho-Pham et al. 2012, Vietnam[129] CS/LS 49 g/d;  0.92g/Kg/d DXA, 
BTM 
Postmenopausal Buddhist Nuns  210 BMD, CTX, PINP 
Hoppe  et al. 2000,  Denmark[54] CS 73-82g/d  DXA 10 year old children 105 BMC, BA 
Horiuchi et al, 2000, Japan[32] CS TP: 62.5g/d 
SP: 12.6g/d 
DXA Post F, 52-83y 85 BMD,OC,BAP,PYD, DPYD 
 
Hu et al, 2014,  USA[130] CS TP: 11.6-20.4% energy  DXA, 
QCT 
801 women and 857 men (age 62+/-
10 years) 
1658 BMD  
Ilich et al, 2003, USA[131] 
 
CS 1.04 g/kg/d DXA Older F, >5 post, 68.7+/-7.1y 136 BMD, BMC 
Iuliano-Burns et al, 2005, AUS[132] CS 76g/d DXA 7-20 year old Male twins 
(Monozygotic n=30) and Dizygotic 
(n=26)  
56 BMC, CT, PW, EW 
Jaime et al, 2006, Brazil[33] 
 
CS 1.2 g/kg/d DXA  Men- Over 50y 277  BMD 
Jones et al. 2001, Tasmania[55] 
 
CS 83g/d DXA Boys and Girls Aged 8 years old 330   BMD 
Knurick et al. 2015, USA[34] 
 
CS 69-97g/d DXA Adult men and women, 18-50 y  81 BMD 
Kumar et al, 2010, India[35] CS 45.7g/d DXA Women aged 20-69 years 225 BMD 
 
Lacey et al, 1991, Japan[36] CS 1.35 g/kg/d SPA Asian pre F(35-40y) and post F (55-
60y) 
178  BMC 
 
Langsetmo et al., 2015 Canada[62] LS 0.79g/Kg/d  DXA Men and women aged over 25 years 
old 
6510 BMD 
36 
 
  
 
Study Design Mean Protein ** Method  Population n Outcomes measured 
Lau et al, 1998, China[37] 
 
CS 0.65 g/kg/d DXA  Vegetarian Post F, 70-89y 76  BMD 
Libuda et al. 2008, Germany[133] CS 1.3 g/Kg/d pQCT 228 Children and adolescents 8-14 
years old 
  
Libuda et al. 2011, Germany[134] CS 42.7-46.1 g/d pQCT Pre-pubertal children 107 
 
BMC, Cortical Area 
Loenekke et al. 2010,  USA[50] CS 72-91g/d DXA Males and Females, 22+/-3 years 27 BMD, BMC 
MacDonald et al, 2005, UK[135] CS 79.4g/d BTM, 
DXA 
45-54y women 5119 PYD, DPYD, BMD 
Meng et al. 2009 AUS[136] LS 80.6 g/d,  1.2 g/kg/d DXA Community-dwelling premenopausal 
women aged 75 +/- 3 years old 
862 BMC 
Metz et al, 1993, USA[137] 
 
CS 1.24 g/kd/d SPA Pre F Caucasian (24-28y) 38 BMD, BMC 
Michaelsson et al, 1995, Sweden[38] 
 
CS 59 g/d DXA  F 28-74y, Caucasian 175 BMD, OC 
Nakamura et al, 2004, Japan[39] CS 1.29 g/kg/d BTM Elderly post F, mean age=68.3y , 
range 43-79 
43 OC,BAP,DPYD,NTX 
Neville et al, 2002, UK[138] CS 66-98 g/d DXA 238 M and 205 F, at both 15 and 20-
25 y  
443 BMD 
New et al, 1997, UK[40] CS 81+/-22 g/d DXA Women aged 44-50 years 
(Premenopausal) 
994 BMD 
Oh et al, 2013, Korea[102] CS TP   45.0-52.3 g/d QUS  Men and POM F aged 50-70 years 3330  Calcaneal Bone Stiffness 
Index 
 
Orozco et al, 1998, Spain[41] CS TP: 73.4(17.9) g/d DXA Premenopausal women aged 42years 
old 
76 BMD 
Orwoll et al, 1987, USA[42] 
 
CS - CT,SPA Men 154 BMC 
Pearce et al. 2010, UK[139] CS Median: 87.7g/d Bone 
Markers 
Men aged 49-52 years 412 CTX 
Promislow et al, 2002 USA[140] 
 
CS 72.5 g/d DXA M/F 55-92y; 572F 388M 960 BMD 
Quintas et al, 2003, Spain[43] CS 1.4-1.7g/d DPA Pre F 164 BMD 
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Rapuri et al, 2003, USA[44] CS 53.7-71.2 g/d DXA Post F- 
 65-77y 
473 BMD,NTX, OC 
Rubinacci et al, 1992, Italy[45] CS 68-83g/d SPA  Post F  120 BMC 
 
Sahni et al. 2013, USA[141] CS/LS 81g/d (Men) 
77g/d (Women) 
DXA 1,280 men and 1,639 women 2919 BMD 
Tanaka et al, 2001, Japan[142] CS 1.3 g/Kg/d QUS Pre F-  
18-22y 
965 Stiffness Index Calcaneus 
Teegarden et al, 1998, USA[46] 
 
CS 1.21 g/Kg/d DXA  Young pre F 215 BMC, BMD 
Thorpe et al, 2008, USA[47] CS 74.7g/d DXA Postmenopausal women mean age 
68+/-6 years 
161 BMD 
Tylavsky and Anderson, 1988, 
USA[143] 
CS 1.01 g/Kg/d 
 
SPA 60-98y elderly F 375  BMC, BMD 
Vatanparast et al, 2007, Canada[144] CS 20-25 years: 68-119g/d 
 
DXA Young adults (59 males, 74 females) 133 BMC, BMD 
Wang et al, 1997, USA[48] 
 
CS 0.97 g/Kg/d DXA  Older post F 125 BMD, BMC 
Wang et al. 1999, USA[145] 
 
CS 1.05 g/Kg/d QUS 63 18-18 year old women 63 BUS, SOS 
Weikert et al, 2005, Germany[146] 
 
CS 67.9g/d QUS F 35-67y 8178 Os calcis 
Whiting et al, 2002, Canada[147] 
 
CS 1.15 g/Kg/d DXA  M 39-42y 57 BMD 
Yazdenpanah et al, 2007, The 
Netherlands [148] 
 
CS 81.3g/d , 1.1g/Kg/d DXA Men and Women aged 55 years and 
over 
5304 BMD 
Zhang et al. 2010, China[149] LS 1.7 g/Kg/d DXA 757 Girls (Mean age 10 years) 757 BMC 
AP, animal protein; BA, Bone area; BAP, Bone Alkaline Phosphatase; BMC, bone mineral content; BMD, bone mineral density; BTM, Bone 
turnover markers;  BUA, Broadband Ultrasound Attenuation; CS, Cross-sectional Study; CT, Computer Tomography; DPA, Dual Photon 
Absorptiometry; DPYD, Deoxypyridinoline; DXA, Dual energy x-ray absorptiometry; EW, Endosteal Width; HPO, Hydroxyproline; HR-pQCT, 
High resolution Peripheral Computed Tomography; LS, Longitudinal Study; NTX, N-terminal Telopeptide of Collagen; pQCT, Peripheral 
Quantitative Computer Tomography; OC, Osteocalcin; P1NP, Procollagen type 1 N-Terminal Propeptide;  PW, Periosteal Width; PYD, 
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Pyridinoline; QUS, Quantitative Ultrasound; SOS, Speed of Sound; SP, soy protein; SPA, Single photon Absorptiometry; SSI, Strength-Strain 
Index; TP, total protein; VP, vegetable protein.   
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Table 2: Characteristics of the 29 studies reporting fracture or osteoporosis diagnosis data (6 of which also in table 1): Cohort and cross-
cultural studies.  
 
Studya  Mean 
Protein 
Populatio
n  
Lengt
h 
Total n Fracture/ 
BMD site 
Protein 
type 
Parameter Confounder Adjustments 
Abelow et al, 
1992, USA 
cross 
cultural[150] 
10.4g/d-
77.8g/d 
AP 
F aged 
over 50y 
- 34 
studies, 
16 
countrie
s 
Hip 
fracture  
 
AP Fracture 
Incidence 
Age 
Beasley et al. 
2014, 
USA[119] 
<13.3% to 
≥15.6% of 
energy  
intake from 
protein 
Women 
aged 50-
79 y at 
baseline 
6y 144,580 Any, Hip, 
Spine, 
Forearm 
TP 
 
HR 
 
Age, BMI, race-ethnicity, calibrated energy intake, general 
health, physical activity, history of fracture at age 55 y, history 
of parental fracture, current smoking, corticosteroid use, 
glucocorticoid use, treated diabetes, 
rheumatoid arthritis, and hormone use 
Dargent-
Molina et al, 
2008, 
France[57] 
TP:46(7.5)
g/d, AP:29 
(8.8) g/d, 
VP:12(3.0)
g/d 
POM 
women 
8.37y 36217 
(2408 
with 
fracture) 
Any low  
impact 
fracture 
TP 
AP 
VP 
RR 
 
Adjusted for BMI, physical activity, parity, maternal history of 
hip fracture, HT use, smoking status, 
and alcohol intake 
Feskanich et 
al, 1996, 
USA[59] 
79.6 g/d 
median 
F, 35-59y  12y 85,900 Forearm,
Hip, 
Fracture 
AP 
TP 
VP 
RR 
 
Age, BMI, vigorous activity per week; menopausal status, use 
of postmenopausal hormones; cigarette smoking; use of 
thyroid hormone medication, thiazide diuretics and 
alcohol/caffeine. 
Frassetto et 
al, 2000, 
USA cross 
cultural[151] 
48 to 110.9 
g/d 
F aged 
over 50y 
 33 
countrie
s 
Hip 
fracture 
 
TP 
AP 
VP 
Hip 
Fracture 
Incidence 
- 
Gunn et al, 
2014, New  
Zealand[28] 
79 g/d POM 
women, 
60 years 
of age 
DXA 
 
Cross-
section
al 
142 Osteoporo
sis 
diagnosis 
 
TP 
Protein 
intake (g) 
by BMD 
diagnosis 
 
- 
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Studya  Mean 
Protein 
Populatio
n  
Lengt
h 
Total n Fracture/ 
BMD site 
Protein 
type 
Parameter Confounder Adjustments 
Key et al, 
2007, 
UK[152] 
Women: 
73.1 (21.6) 
g/d 
77.8(22.6) 
g/d 
Men and 
Women 
aged 20-
89 years 
5.2y 26 749 
women 
and 
7947 
men  
All sites, 
fractures 
(including 
high 
trauma) 
TP 
 
Incident 
Rate Ratio 
 
 
Method of recruitment and adjusted for age, smoking, intakes 
of energy and each other nutrient, alcohol consumption, body 
mass index, walking, cycling, vigorous exercise, other 
exercise, physical activity at work, marital status and, for 
women, parity and use of hormone replacement therapy  
Langsetmo et 
al, 2015, 
Canada[62] 
TP: 
0.79(0.60-
1.03). 
AP:17.6(12
.8-23)g/d 
VP:24.3(18
.8-31.0)g/d 
M and F, 
aged 25-
49 and 
≥50 years 
 
 
 
 
5y 6510 Fragility 
fracture:  
n=4543 
 
Main 
fracture: 
n=4570 
TP 
 
HR 
 
 
Age, height, TEI, centre (women only), education, smoking, 
alcohol intake, physical activity, sedentary hours, calcium and 
vitamin D supplement use, hormone therapy (women only), 
bisphosphonate use (women only), and diagnosis of 
osteoporosis (women only) 
Meyer et al, 
1997, 
Norway[61] 
 
0.8 M/F 
(mean age 
47.1y) 
11.4y   19752 F  
20035 
M 
HF- F 
HF-M 
AP 
 
RR Age at screening, body height, body mass index, serf-reported 
physical activity at work and during leisure time, diabetes, 
disability pension, marital status, and smoking 
Misra et al, 
2011, 
USA[63] 
 
64g/d 
(energy 
adjusted) 
M/F mean 
age=75 
years 
11.6y 946 
(n=100 
HF) 
HF TP HR 
 
 
Age, sex, weight, height and total energy intake 
Munger et al, 
1999, 
USA[58] 
 
1.2 units 
g/Kg/d 
Postmeno
pausal F 
(55-69y)  
1-3y 32 050 HF AP, TP, 
VP 
RR 
 
Age, body mass index, number of pregnancies, smoking, 
alcohol use, estrogen use, and physical 
activity. 
Mussolino et 
al, 1998, 
USA[60] 
 
<56g/d -
>98g/d 
Caucasian 
M (45-
74y) 
22y 2879 HF TP RR BMI, previous fracture, smoker, physical activity, alcohol, 
chronic health condition, calcium intake, weight loss. 
Sahni et al, 
2010, 
USA[64] 
 
Men 
TP: 75-
79.0g/d 
Men and 
women 
aged 
7 to 14 
years 
3656 HF TP, AP 
VP, 
AP:VP 
ratio 
HR 
 
 
 
Sex and menopause status (group 1: men; group 2: 
premenopausal women; group 3: postmenopausal women), 
age(years), weight at baseline (kg), height at baseline (m), 
physical activity index, intake of energy (MJ/day) and total 
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Studya  Mean 
Protein 
Populatio
n  
Lengt
h 
Total n Fracture/ 
BMD site 
Protein 
type 
Parameter Confounder Adjustments 
 AP: 52-54 
g/d , VP: 
23-25g/d 
 
mean= 55 
(9.9)years 
 
 
 
vitamin D (IU/day), and smoking status (current versus 
former/never) and calcium intake 
Sellmeyer et 
al, 2001, 
USA[153] 
 
49.8g/d F  > 65y 
old 
7.0y 
+/- 
1.5y 
1035  HF VP, AP, 
AP:VP 
RR 
 
Age and body weight 
Zhong et al, 
2009 
USA[154] 
Mean(SE)=
61+/-0.8 
g/d 
POM 
women 
50+ y old 
<7y 2006 All 
fragility 
fractures  
TP OR  
 
Age, race, body mass index (underweight/normal, overweight, 
obese), physical activity level, smoking status, alcohol use 
(heavy, moderate/none), hormone use, general health status, 
osteoporosis, arthritis, vision impairment, and stroke. 
 
Zhang 
2005[155] 
SP: 9.6g/d 
Non Soy: 
134g/d 
Women 
aged 40-
70 years 
old 
4.5 y 24403 All 
fractures 
SP RR Age, body mass index, hours of exercise per week, cigarette 
smoking, alcohol consumption, history of diabetes mellitus, 
level of education, family income, season of recruitment, and 
intakes of total calories, calcium, non-soy protein, fruits, and 
vegetables 
aAll studies are cohorts unless otherwise stated. AP, Animal Protein; BMD, Bone Mineral Density; HR, Hazard Ratio; OR, Odds Ratio; POM, 
Postmenopausal; RR, Relative Risk; SP, Soy Protein; TEI, Total Energy Intake; TP, Total Protein; VP, Vegetable Protein. 
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Table 3: Characteristics of the 29 studies reporting fracture or osteoporosis diagnosis data (6 of which also in table 1): 13 Case-control 
studies 
Study Protein 
intake 
Measure n Group/outcome Confounder Adjustments 
Alissa et al, 2011, 
Saudi Arabia,  Non-
Prospective [117]  
 
77g/d DXA 122 POM Women, aged 
50-60 years 
Normal BMD vs. 
Osteopenic 
Non adjusted for confounders 
 
Chevalley et al. 2011, 
Switzerland 
Prospective[156] 
 
47-63 g/d DXA 176 boys- measured 
during pre-puberty and 
adolescence 
Fracture vs. No Fracture Non adjusted for confounders 
Chiu et al, 1997, 
Taiwan  Non-
Prospective[23] 
 
1.09  g/Kg/d DPA (BMD) 258 Older post F OR for Osteopenia 
diagnosis: LS and FN 
Age, BMI, physical activity, calcium intake, non-
protein energy intake, long term vegan/vegetarianism 
Coin et al, Italy, 2008 
Non-Prospective[25] 
 
1.02 g/Kg/d DXA 136 Males, mean age 
73.9+/-5.6 years 
OR for  low THBMD BMI 
Farrin et al. 2008, Iran 
Non-prospective[157] 
81.4g/d DXA 58 POM women LSBMD based diagnosis: 
Normal/Osteopenic/ 
Osteoporotic 
Unadjusted 
Kim et al, 2008, Korea 
Non-prospective[158] 
 
TP= 60g/d, 
AP= 19g/d, 
VP= 40g/d 
DXA 271 POM women: 134 
cases and 137 controls 
Osteoporotic  vs. 
Non-Osteoporotic 
TP, AP, VP 
Age, smoking, alcohol drinking, BMI, exercise, 
family history of osteoporosis, and energy intakes 
Martinez-Ramirez  et 
al, 2012, Spain 
Non-Prospective[65] 
TP:105 (1.0) 
g/d. AP:66-
70 (1.3) g/d. 
VP: 38 
(0.63)g/d,  
Aged 65 
years or 
over, cases  
167 cases and 167 
controls 
OR : All low  energy 
fractures. TP, AP, VP, 
AP:VP ratio 
 
Age, sex, energy intake, vegetable protein intake or 
animal protein intake, serum vitamin C, calcium 
intake, underlying chronic disease, home access, 
Katz’s index, physical activity, HDL cholesterol and 
MUFA/PUFA intake. 
Nieves et al, 1992, 
USA 
Non-prospective[66] 
 
<24g/d to 
>55g/d 
F 50 to 103y  329 (161 cases, 168 
controls) 
OR Hip fracture Hospital, age, BMI, oestrogen use, chronic disease 
status 
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AP, Animal Protein; BMD, Bone Mineral Density; DPA, Dual Photon Absorptiometry; DXA, Dual X-Ray Absorptiometry; LSBMD, Lumbar 
Spine Bone Mineral Density; OR, Odds Ratio; POM, Postmenopausal; PRE, Premenopausal; THBMD, Total Hip Bone Mineral Density; TP, 
total protein; VP, vegetable protein  
Park et al, 2014, Korea 
Non-prospective[159] 
 
81.93+/-
52.31 g/d 
DXA 1157 PRE women Z-Score ≥0 , Z-score<0  Non-adjusted 
Perez-Durillo et al, 
2011, Spain 
Non-prospective[160] 
Cases 60 
(19)g/d; 
controls 94 
(19) g/d 
Women  
> 65 y 
44 cases and 42 controls TP, Hip fracture c BMI, carbohydrate intake and calcium intake 
Preisinger et al, 1995, 
Austria 
Non-prospective[161] 
 
15 % total 
energy, 45-
96 g/d 
Osteoporosis  23 POM women 50-70 
years old 
TP, AP, VP, Osteoporotic 
vs. Non Osteoporotic 
Not required as just intake data 
Samieri et al, 2013, 
France 
Prospective [162] 
 
70-76 g/d Men and 
women >65y 
1482 Incident fracture of  hip, 
spine or wrist 
Not adjusted for confounders 
Wengreen et al, 2004, 
USA 
Non-prospective[67] 
1.2g/Kg/d 50-89y  M/F 2501 (1157 cases, 1334 
controls) 
Cases Controls, Hip (OR), 
TP AP VP 
 
 
BMI, smoking, alcohol, physical activity, oestrogen 
use, gender, total Calcium and Vitamin D intakes 
(diet and supplements), potassium intake, age. AP 
model also adjusted for VP intake, VP model also 
adjusted for AP intake. 
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Table 4: Characteristics of the 30 intervention studies reporting randomised control trials of dietary protein supplementation on bone 
health outcomes 
Study, Country, 
Duration 
Baseline protein intake 
Supplement  vs control 
Change in 
protein intake 
Subject Total n 
Outcomes Measured 
Alekel et al, 2000, USA, 
24wks[73] 
No information in paper 40g/d Soy vs Whey + 40g/d N = 24 SPI+; N = 24 
SPI-, N = 21 whey 
protein (control) PERI F 
BMC, BMD, BAP 
Aoe et al, 2001, Japan[96] No information in paper 40mg/d MBP vs Placebo + 40mg/d 
(MBP) 
32 PRE F % change data only: 
Calcaneal BMD 
Aoe et al 2005, Japan, 
6mo[69] 
 
No information in paper 40mg/d MBP vs Inactive placebo +40mg/d 
(MBP) 
27 PERI F NTX, OC, BMD 
Arjmandi et al, 2003, 
USA, 3mo[87] 
Mean (SE): Soy group – 
60(6)g/d, MBP group 
(75(9) g/d  
40g/d Soy protein vs MBP +40g/d 42 POM F BAP, DPYD 
Cao et al, 2011, USA 
Crossover study 14wks  
(7 weeks each arm)[1] 
No information in paper 61g/d diet (‘lower protein control- 
US daily recommendation) vs. 
118g/d (‘higher protein’ group) 
diet 
+/-57g/d N=16  40-75 year old 
POM F,  
NTX, DPYD 
Ceglia et al, 2009 
Crossover study 41 d[82]  
Mean (SD): 69.1 (22.1) g/d Mean (SD)2.1(2.02) Low vs.  
96.7(5.7) High 
-37.0 g/d (low) 
 +27.6 g/d 
(high) 
 
M/F 54-82 years old  
N=10  
OC, NTX  
Cuneo et al, 2010, 
Brazil[88] 
Mean (SD) : 67(18.8) g/d 
(placebo), 61.9(24) g/d 
(collagen) 
Hydrolysed collagen (10g/d 
protein) vs. maltodextrin placebo  
+10 g/d N=36 collagen, N=35 
placebo, 45-65 year old 
POM F 
BAP, CTX, OC 
Dalais et al, 2003, AUS, 
3mo[89] 
 
109(7) g/d Soy group, 
112(6)g/d Placebo 
40g Soy protein vs casein placebo +40g/d 106 POM F 50-75 y PYD, DPYD 
Dawson-Hughes et al 
2004,USA, 63d[91] 
 
No information in g (17-
18% of total energy)  
Mean(SD): High: 57.6(8.2) g/d 
protein , Low: 2.8(0.5) g/d protein 
No baseline 
data in grams 
32 Elderly M/F NTX, OC 
Evans et al, 2007, USA 
Crossover study, 9 
months[78] 
No information in paper 25.6g Soy protein isolate (I) vs. 
Milk protein isolate (p),  
+25.6g/d Postmenopausal women 
N=22, Mean age 63 
years 
BMD, BAP, CTX 
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Study, Country, 
Duration 
Baseline protein intake 
Supplement  vs control 
Change in 
protein intake 
Subject Total n 
Outcomes Measured 
exercise counterbalanced across 
groups (1/2 in each group 
exercise, ½  in each group no 
exercise) 
Hunt et al, 2009, USA, 7 
wks 
Cross over study [83] 
63(15) g/d LC 
69(17) g/d HC 
Protein g/d: LCLP 58, LCHP 112, 
HCLP 59, HCHP 115 
 
 
LCLP -5g/d, 
LCHP +49g/d, 
HCLP -10g/d, 
HCHP +46g/d 
N=13 in two LC arms, 
n=14 in two HC arms 
Post F 
DPYD, OC, BAP, 
TRAP 
 
Ince et al 2004, USA, 
2wks  
Crossover study[94] 
 
1.1 g/kg/d Change to low (0.8g/Kg/d) 
protein diet 
-0.2g/Kg/d 39 Pre F, 22-39y NTX, OC 
Jenkins et al, 2003, USA, 
2mo 
Crossover study[85] 
No information in g 
(18% of total energy) 
Vegetable  diet: 189g/d protein, 
(16% total energy) vs Control  
diet: 111g/d protein (27% total 
energy) 
+78g/d 20 Middle aged M/F NTX, BAP 
Kenny et al, 2009, USA, 1 
year [74] 
Mean +/-SD : Soy group- 
62.5 (13.7) g/d, Mixed 
control group- 57.0(21.9) 
18g Soy protein (I) vs. 18g Mixed 
control protein (Casein, Whey and 
Egg) (p). 
No isoflavones in these two study 
arms 
+18g/d Women over 60 years 
old (mean=71y) 
BMD, BAP, NTX 
Kerstetter et al, 1999, 
USA, 4d 
Crossover study[80] 
1.0g/Kg/d  High (2.1g/kg/d)vs low 
(0.7g/kg/d) protein 
+1.1g/Kg/d 
High 
-0.3g/Kg/d 
Low 
16 Pre F, 20-40g OC,BAP, NTX 
Kerstsetter et al, 2015, 
USA, 18mo[68] 
Mean (SEM): 72.9(1.8) 
Maltodextrin Group, 
73.9(1.9) Whey Group 
45g Whey protein or Isocaloric 
maltodextrin  
+45g/d Men over 70 y and 
women over 60 years, 
n=121 
BMD, P1NP, CTX, 
OC  
Khalil et al, 2002, US, 
3mo[86] 
 
No information in paper Soy vs Milk protein (40g) +40g/d 64 M, 59.2+/-17.6y BAP, DPYD 
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Study, Country, 
Duration 
Baseline protein intake 
Supplement  vs control 
Change in 
protein intake 
Subject Total n 
Outcomes Measured 
Lampl et al. 1978, New 
Guinea, 8 mo[92] 
11g/d Normal diet (11g/d)vs. normal 
diet plus 20g/d milk protein 
supplement 
31g/d 7-13 year old Bundi 
children, male and 
female, with low protein 
intakes 
Periosteal breadth , 
Endosteal breadth, 
Compact bone breadth  
Martin-Bautista et al. 
2011, Spain, 4 mo[93] 
Mean(SD): 34.1(26.0)g/d 
Collagen , 33.0(18.1)g/d 
Placebo  
Drink containing partially 
hydrolysed collagen  vs. placebo 
drink 
+4.25g/d  60 children aged 6-11 
years 
BAP, OC, TRAP, 
CTX 
Roughead et al, 2003, 
USA, 8wk 
Cross over study[81] 
 
No information in paper High meat diet: 117g/d  (20% of 
energy) versus low meat diet: 
68g/d (12% of energy) 
+49g/d 15 POM F HPO, OC, NTX, BAP 
Schurch et al, 1998 
Switzerland, 6mo[95] 
 
 
Mean (SD) 45.0 (15.2) g/d 
protein group vs. 51.0 
(19.0) g/d control group 
Total protein (20g/d)  vs placebo +20g/d 82 Elderly M/F 80.7y+/-
7.4 
%Change data only: 
DPYD, FSBMD, OC, 
PFBMD, PYD, BMD 
Shapses et al, 1995, USA, 
crossover study,  5d[84] 
0.99 g/Kg/d (no 
information in g) 
LPHC(0.44g/Kg/D protein, p) vs. 
HPHC (2.71g/kg/d, I) 
Calcium in both 
groups=1600mg/d 
-0.55g/Kg/d 
Low 
+1.70g/Kg/d 
High 
21-42 year old males 
and females 
HPO 
Spence et al, 2005, USA, 
crossover study 28d per 
phase[79] 
No information in paper Soy protein isolate without 
isoflavones diet  (96g/d)  vs. 
casein-whey protein diet (91g/d) 
+0 (as 
comparing 
protein type 
not dose, 
although 5g/d 
difference in 
actuality) 
N=15 Post F BAP ,OC ,NTX   
Tkatch et al, 1992, 
Switzerland, 38days[72] 
No information in paper 20.4g/d Protein in nutritional 
supplement  vs. the same 
nutritional supplement without 
protein 
+20.4g/d 62 M/F elderly, mean 
age 82y 
BMD,OC 
Toba et al 2001, Japan, 
16d[90] 
No information in paper MBP (300mg/d) vs inactive 
placebo 
+300 mg/d 
MBP 
30 M, 36.2y+/-8.5 NTX,OC 
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Study, Country, 
Duration 
Baseline protein intake 
Supplement  vs control 
Change in 
protein intake 
Subject Total n 
Outcomes Measured 
Uenishi et al, 2007, Japan, 
6mo[70] 
 
No information in paper 40mg/d 
MBP vs inactive placebo 
+40mg/d MBP 35 Pre F BMD 
Vupadhyahula et al, 2009, 
USA[75] 
Mean (SD): 62.9(1.9) Soy 
protein group, 61.3(1.6) 
Milk Protein group 
 
25g soy protein (no isoflavones), 
25g milk (casein, whey) protein 
+25g/d 203 Post F Mean (SE) 
age 64  0.6)y 
BMD, NTX 
Yamamura et al, 2002, 
Japan[77] 
 
No information in paper MBP(40mg)  vs inactive placebo +40mg/d MBP 33 Pre F BMD 
Zhu et al, 2011, AUS, 
2y[76] 
Mean(SD): 76(18)g/d High 
protein group, 76(16) Low 
protein placebo group 
High protein drink 30g vs. low 
protein drink (placebo) 2.1g 
+27.9g/d  219  70-80 year old 
women 
vBMD, BMD 
Zou et al 2009, China, 8 
mo[71] 
No information in paper Milk with 40mg MBP  vs. Milk 
without MBP  
+40mg/d MBP 57 women, 20 years old BMD 
      
AUS, Australia; BAP, Bone Alkaline Phosphatase; BMC, Bone Mineral Content; BMD, Bone Mineral Density; CTX, C-Terminal Peptide of 
Collagen; DPYD, Deoxypyridinoline; FSBMD, Femoral Shaft Bone Mineral Density;  HCHP, High Calcium High Protein; HCLP, High 
Calcium Low Protein; HPO, Hydroxyproline; LCHP, Low Calcium High Protein;  LCLP, Low Calcium Low Protein; MBP, Milk Basic Protein; 
NTX, N-Terminal Peptide of Collagen; OC, Osteocalcin; P1NP, Procollagen type 1 N-Terminal Propeptide; PERI, Perimenopausal; PFBMD, 
Proximal Femoral Bone Mineral Density; POM, Postmenopausal; PRE, Premenopausal; PYD, Pyridinoline; SPI, Soy Protein Isolate; TRAP, 
Tartrate Resistant Alkaline Phosphatase; vBMD, volumetric Bone Mineral Density 
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Figure Captions 
 
Fig. 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses flow 
diagram to illustrate search results 
Fig. 2 Protein intake and all low trauma fractures (lowest intake category: RR=1) Animal 
(top) Vegetable (middle) Total Protein (bottom)  
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